Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Total Current Liabilities (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Total Current Liabilities for 2 consecutive years, with $12.5 million as the latest value for Q3 2023.

  • On a quarterly basis, Total Current Liabilities fell 7.3% to $12.5 million in Q3 2023 year-over-year; TTM through Sep 2023 was $12.5 million, a 7.3% decrease, with the full-year FY2022 number at $13.0 million, changed N/A from a year prior.
  • Total Current Liabilities was $12.5 million for Q3 2023 at LENZ Therapeutics, up from $12.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $14.3 million in Q1 2023 to a low of $12.1 million in Q2 2022.